Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric Subjects

NCT05097079 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company/sponsor business decision

Conditions

Sialorrhea

Interventions

DRUG: MYOBLOC Low Dose
DRUG: MYOBLOC High Dose
DRUG: Placebo

Sponsor

Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC